Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP). (Q46921992)
Jump to navigation
Jump to search
scientific article published in March 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP). |
scientific article published in March 2008 |
Statements
1 reference
Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP). (English)
1 reference
Ralph Graeser
1 reference
Da-Eun Chung
1 reference
Norbert Esser
1 reference
Sandra Moor
1 reference
Christoph Schächtele
1 reference
Clemens Unger
1 reference
Felix Kratz
1 reference
1 March 2008
1 reference
122
1 reference
5
1 reference
1145-1154
1 reference
Identifiers
1 reference
1 reference